Published in J Biol Chem on June 25, 1992
Protein kinase C isoenzymes: divergence in signal transduction? Biochem J (1993) 3.86
Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J (1993) 2.64
Persistent activation of the zeta isoform of protein kinase C in the maintenance of long-term potentiation. Proc Natl Acad Sci U S A (1993) 2.12
Three distinct mechanisms for translocation and activation of the delta subspecies of protein kinase C. Mol Cell Biol (1998) 1.32
Ras-dependent signal transduction is indispensable but not sufficient for the activation of AP1/Jun by PKC delta. EMBO J (1994) 1.30
A novel pathway for adrenergic stimulation of cAMP-response-element-binding protein (CREB) phosphorylation: mediation via alpha1-adrenoceptors and protein kinase C activation. Biochem J (2002) 1.03
Protein kinase C bound to the Golgi apparatus supports the formation of constitutive transport vesicles. Biochem J (1996) 0.90
Different roles of protein kinase C-beta and -delta in arachidonic acid cascade, superoxide formation and phosphoinositide hydrolysis. Biochem J (1993) 0.84
TC-PTP directly interacts with connexin43 to regulate gap junction intercellular communication. J Cell Sci (2014) 0.83
Selective translocation of protein kinase C-delta in PC12 cells during nerve growth factor-induced neuritogenesis. Mol Biol Cell (1995) 0.82
Protein kinase C-mediated phospholipase A2 activation, platelet-activating factor generation and prostacyclin release in spontaneously beating rat cardiomyocytes. Biochem J (1993) 0.81
Different pathways for control of Na+/H+ exchange via activation of the thrombin receptor. Biochem J (1994) 0.80
Differential effects of phorbol ester on growth and protein kinase C isoenzyme regulation in human hepatoma Hep3B cells. Biochem J (1998) 0.80
Regulation of protein kinase C isozymes during early postnatal hippocampal development. Brain Res (2009) 0.78
The co-mitogenic combination of transforming growth factor beta 1 and bombesin protects protein kinase C-delta from late-phase down-regulation, despite synergy in diacylglycerol accumulation. Biochem J (1996) 0.78
Protein kinase C-dependent prostaglandin production mediates angiotensin II-induced atrial-natriuretic peptide release. Biochem J (1994) 0.77
Changes in calcium influx affect the differentiation of murine erythroleukaemia cells. Biochem J (1995) 0.77
Investigation of the inhibitory effects of HA-1077 and Y-32885 on the translocation of PKCbetaI, PKCbetaII and PKCzeta in human neutrophils. Mediators Inflamm (2001) 0.77
Evidence for a role of conventional protein kinase-C alpha in the control of homotypic contacts and cell scattering of HT-29 human intestinal cells. Biochem J (1996) 0.76
Toward understanding the impacts of sediment contamination on a native fish species: transcriptional effects, EROD activity, and biliary PAH metabolites. Environ Sci Eur (2016) 0.75
Tumor-promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors. Science (1978) 3.00
Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene (1993) 2.99
Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. Oncogene (1989) 2.67
Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences. DNA (1988) 2.61
Tumour promotor induces plasminogen activator. Nature (1976) 2.60
Induction of the Z conformation in poly(dG-dC).poly(dG-dC) by binding of N-2-acetylaminofluorene to guanine residues. Proc Natl Acad Sci U S A (1981) 2.54
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med (1996) 2.39
Analysis of type 5 adenovirus transformation with a cloned rat embryo cell line (CREF). Proc Natl Acad Sci U S A (1982) 2.36
Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. Science (1976) 2.34
A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res (2000) 2.32
Structure of the fluorescent Y base from yeast phenylalanine transfer ribonucleic acid. J Am Chem Soc (1970) 2.21
Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology (1996) 2.16
PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J (1995) 2.14
Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture. Proc Natl Acad Sci U S A (1977) 2.09
Direct detection and amplification of Helicobacter pylori ribosomal 16S gene segments from gastric endoscopic biopsies. Diagn Microbiol Infect Dis (1991) 2.06
Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res (1992) 1.95
Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. J Cell Physiol (2000) 1.94
Retracted A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity. Int J Cancer (1989) 1.93
Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res (1997) 1.92
Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell (1988) 1.91
Oligonucleotide probe for detection and identification of Campylobacter pylori. J Clin Microbiol (1989) 1.90
Test for malignant transformation of rat liver cells in culture: cytology, growth in soft agar, and production of plasminogen activator. J Natl Cancer Inst (1977) 1.86
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci U S A (1993) 1.84
Mechanism of tumor promoter inhibition of cellular binding of epidermal growth factor. Proc Natl Acad Sci U S A (1979) 1.82
Mitochondrial DNA is a major cellular target for a dihydrodiol-epoxide derivative of benzo[a]pyrene. Science (1980) 1.78
Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence. J Natl Cancer Inst (1997) 1.78
A preparative method for obtaining enucleated mammalian cells. Biochem Biophys Res Commun (1975) 1.71
Epidermal growth factor, like phorbol esters, induces plasminogen activator in HeLa cells. Nature (1978) 1.70
Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2. Eur J Biochem (1995) 1.69
Structures of benzo(a)pyrene--nucleic acid adducts formed in human and bovine bronchial explants. Nature (1977) 1.68
A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene--DNA adducts in animal and human tissues by immunoassays. Carcinogenesis (1982) 1.66
Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification. Oncogene (1991) 1.59
Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4. J Natl Cancer Inst (2001) 1.59
Identification of receptors for phorbol ester tumor promoters in intact mammalian cells and of an inhibitor of receptor binding in biologic fluids. Proc Natl Acad Sci U S A (1981) 1.59
Isolation of cDNA clones encoding protein kinase C: evidence for a protein kinase C-related gene family. Proc Natl Acad Sci U S A (1987) 1.59
Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element. Mol Cell Biol (1999) 1.58
Cellular Moloney murine sarcoma (c-mos) sequences are hypermethylated and transcriptionally silent in normal and transformed rodent cells. Mol Cell Biol (1982) 1.58
Inhibition of protein kinase C by tamoxifen. Cancer Res (1985) 1.56
Letter: Benzo[a]pyrene-nucleic acid derivative found in vivo: structure of a benzo[a]pyrenetetrahydrodiol epoxide-guanosine adduct. J Am Chem Soc (1976) 1.53
The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene (1993) 1.50
Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J Chronic Dis (1982) 1.49
Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay. Cancer Res (1980) 1.49
Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties. J Biol Chem (1996) 1.49
Isolation and structure determination of the fluorescent base from bovine liver phenylalanine transfer ribonucleic acid. Biochemistry (1973) 1.48
Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res (2001) 1.47
Summary of a scientific conference on preventive nutrition: pediatrics to geriatrics. Circulation (1999) 1.46
Fractionation of rat liver transfer ribonucleic acid. Isolation of tyrosine, valine, serine, and phenylalanine transfer ribonucleic acids and their coding properties. Biochemistry (1969) 1.43
Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. Proc Natl Acad Sci U S A (1996) 1.41
Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. Cancer Res (1998) 1.40
Tumor promoters inhibit morphological differentiation in cultured mouse neuroblastoma cells. Science (1978) 1.39
Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun (1993) 1.38
Rearranged c-mos locus in a MOPC 21 murine myeloma cell line and its persistence in hybridomas. Nature (1984) 1.38
Gaucher disease: genetic heterogeneity within and among the subtypes detected by immunoblotting. Am J Hum Genet (1987) 1.38
Design of a retrovirus-derived vector for expression and transduction of exogenous genes in mammalian cells. Mol Cell Biol (1983) 1.37
Protein kinase C and mammary cell differentiation: involvement of protein kinase C alpha in the induction of beta-casein expression. Cell Growth Differ (1994) 1.37
Action of phorbol esters in cell culture: mimicry of transformation, altered differentiation, and effects on cell membranes. J Supramol Struct (1979) 1.36
Molecular epidemiology: recent advances and future directions. Carcinogenesis (2000) 1.36
Differential excision from DNA of the C-8 and N2 guanosine adducts of N-acetyl-2-aminofluorene by single strand-specific endonucleases. Cancer Res (1977) 1.35
Differences in the transfer RNA's of normal liver and Novikoff hepatoma. Proc Natl Acad Sci U S A (1969) 1.35
A molecular code dictates sequence-specific DNA recognition by homeodomains. EMBO J (1996) 1.34
Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am J Pathol (1999) 1.34
Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol (1995) 1.33
Studies on the effect of cortisone on rat liver transfer ribonucleic acid. Biochemistry (1969) 1.33
CDO: an oncogene-, serum-, and anchorage-regulated member of the Ig/fibronectin type III repeat family. J Cell Biol (1997) 1.32
Nucleoside adducts from the in vitro reaction of benzo[a]pyrene-7,8-dihydrodiol 9,10-oxide or benzo[a]pyrene 4,5-oxide with nucleic acids. Biochemistry (1977) 1.32
Imatinib: a selective tyrosine kinase inhibitor. Eur J Cancer (2002) 1.32
Oncogene-induced transformation of C3H 10T1/2 cells is enhanced by tumor promoters. Science (1984) 1.30
Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma. J Clin Pathol (1997) 1.29
Protein synthesis in a subcellular system from Bacillus stearothermophilus. Biochim Biophys Acta (1966) 1.28
Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth. Br J Cancer (2001) 1.28
EGF induces biphasic S6 kinase activation: late phase is protein kinase C-dependent and contributes to mitogenicity. Cell (1989) 1.28
Modification of ribonucleic acid by chemical carcinogens. IV. Circular dichroism and proton magnetic resonance studies of oligonucleotides modified with N-2-acetylaminofluorene. J Mol Biol (1971) 1.28
Hint1 is a haplo-insufficient tumor suppressor in mice. Oncogene (2006) 1.27
Detection of carcinogen-DNA adducts by radiommunoassay. Nature (1977) 1.26
Membrane effects of tumor promoters: stimulation of sugar uptake in mammalian cell cultures. J Cell Physiol (1979) 1.25
Sequence-specific DNA recognition by the thyroid transcription factor-1 homeodomain. Nucleic Acids Res (1994) 1.25
Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha. J Biol Chem (1993) 1.23
Amplification of the EGF receptor and c-myc genes in human esophageal cancers. Int J Cancer (1988) 1.23
Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. J Interferon Res (1985) 1.23
Modification of ribonucleic acid by chemical carcinogens. VI. Effect of N-2-acetylaminofluorene modification of guanosine on the codon function of adjacent nucleosides in oligonucleotides. J Mol Biol (1974) 1.21
Helicobacter pylori inhibits the G1 to S transition in AGS gastric epithelial cells. Cancer Res (1999) 1.21
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro. Eur J Cancer (2003) 1.20
Current concepts and controversies in chemical carcinogenesis. J Supramol Struct Cell Biochem (1981) 1.20
Monoclonal antibodies to DNA modified by a benzo[a]pyrene diol epoxide. Carcinogenesis (1984) 1.20
Measurement of benzo(a)pyrene-DNA adducts by enzyme immunoassays and radioimmunoassay. Cancer Res (1981) 1.20
Molecular cloning of TPAR1, a gene whose expression is repressed by the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA). Exp Cell Res (1994) 1.20
Patterns of viral DNA integration in cells transformed by wild type or DNA-binding protein mutants of adenovirus type 5 and effect of chemical carcinogens on integration. J Virol (1980) 1.19
Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo. Proc Natl Acad Sci U S A (1996) 1.19
Coding and conformational properties of oligonucleotides modified with the carcinogen N-2-acetylaminofluorene. Proc Natl Acad Sci U S A (1970) 1.19
Phorbol esters stimulate the rapid release of choline from prelabelled cells. Carcinogenesis (1981) 1.19
Quantitative associations between DNA damage in human placenta and maternal smoking and birth weight. J Natl Cancer Inst (1988) 1.19
Interaction of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) with nucleic acids and proteins in vivo and in vitro. Cancer Res (1972) 1.19
A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes. Gastroenterology (1997) 1.18
Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochem Pharmacol (1999) 1.18
Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis. Cell Growth Differ (1996) 1.17
Stat3 orchestrates tumor development and progression: the Achilles' heel of head and neck cancers? Curr Cancer Drug Targets (2010) 1.17
Interactions between adenovirus, a tumor promoter, and chemical carcinogens in transformation of rat embryo cell cultures. Proc Natl Acad Sci U S A (1978) 1.17